CoChat
Cited by 216

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction

Open access
Chirinos, Julio A., Orlenko, Alena, Zhao, Lei, Basso, Michael D., Cvijic, Mary Ellen, Li, Zhuyin, Spires, Thomas E., Yarde, Melissa, Wang, Zhaoqing, Seiffert, Dietmar A., Prenner, Stuart, Zamani, Payman, Bhattacharya, Priyanka, Kumar, Anupam, Margulies, Kenneth B., Car, Bruce D., Gordon, David A., Moore, Jason H., Cappola, Thomas P. · 2020 · Journal of the American College of Cardiology

Abstract

Background: Better risk stratification strategies are needed to enhance clinical care and trial design in HFpEF. Objective: To assess the value of a targeted plasma multi-marker approach to enhance our phenotypic characterization and risk prediction in HFpEF. Methods: We measured 49 plasma biomarkers from TOPCAT trial participants (n = 379) using a Multiplex assay. We assessed the relationship between biomarkers and the risk of all-cause death or heart failure-related hospital admission (DHFA). A tree-based pipeline optimizer platform was used to generate a multimarker predictive model for DHFA. We validated the model in an independent cohort of HFpEF patients enrolled in the Penn Heart Failure study (PHFS, n = 156). Results: Two large, tightly related dominant biomarker clusters were found, which included biomarkers of fibrosis/tissue remodeling, inflammation, renal injury/dysfunction and liver fibrosis. Other clusters were composed of neurohormonal regulators of mineral metabolism, intermediary metabolism, and biomarkers of myocardial injury. Multiple biomarkers predicted incident DHFA, including two biomarkers related to mineral metabolism/calcification (FGF-23 and OPG), 3 inflammatory biomarkers (TNF-alpha, sTNFRI and IL-6), YKL-40 (related to liver injury and inflammation), two biomarkers related to intermediary metabolism and adipocyte biology (FABP-4 and GDF-15), angiopoietin-2 (related to angiogenesis), MMP-7 (related to extracellular matrix turnover), ST-2 and NT-proBNP. A machine-learning derived model using a combination of biomarkers was strongly predictive of the risk of DHFA (Standardized HR = 2.85; 95%CI = 2.03-4.02; P<0.0001) and markedly improved the risk prediction when added to the MAGGIC risk score. In an independent cohort (PHFS), the model strongly predicted the risk of DHFA (Standardized HR=2.74; 95%CI=1.93-3.90; P<0.0001), which was also independent of the MAGGIC risk score. Conclusions: Various novel circulating biomarkers in key pathophysiologic domains are predictive of outcomes in HFpEF and a multi-marker approach coupled with machine-learning represents a promising approach for enhancing risk stratification in HFpEF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.12.069

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

    Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564

  • Spironolactone for heart failure with preserved ejection fraction

    Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809 · cited 1×

    “The design, general characteristics of the study population and primary results of the trial have been previously published.(1-3) Key inclusion and exclusion criteria for TOPCAT are listed in the online supplemental section.”
    Background
  • FGF23 induces left ventricular hypertrophy

    Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027 · cited 1×

    “In animal models, administration of FGF-23 led directly to cardiomyocyte hypertrophy, (18) and increased FGF-23 levels are associated with left ventricular hypertrophy in humans.”
    Background
  • Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes

    Kannan, L., Shaw, P. A., Morley, M. P., Brandimarto, J., Fang, J. C., Sweitzer, N. K., Cappola, T. P., & Cappola, A. R. (2018) · Circulation: Heart Failure · doi:10.1161/circheartfailure.118.005266 · Cited by 245 · cited 2×

    “At the time of enrollment, standardized questionnaires were administered to participants and their physicians to obtain detailed clinical data as described previously.(5,6) Participants with expected mortality of 6 months or less from a non-cardiac condition, as judged by their treating physician, mechanical circulato…”
    MethodSelf-citation

Show all 4 references

Cited by

Metadata

Authors
Chirinos, J. A., Orlenko, A., Zhao, L., Basso, M. D., Cvijic, M. E., Li, Z., Spires, T. E., Yarde, M., Wang, Z., Seiffert, D. A., Prenner, S., Zamani, P., Bhattacharya, P., Kumar, A., Margulies, K. B., Car, B. D., Gordon, D. A., Moore, J. H., & Cappola, T. P.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2020-03
Volume
75
Issue
11
Pages
1281-1295
ISSN
0735-1097 (ISSN-L)
OpenAlex
W3011669549
Cited by
216
References
4
FWCI
15.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.